Study Participants | CD4+CD25– | CD4+CD25+ | CD4+CD25+CD127low/– | CD4+CD25highCD127low/– |
---|---|---|---|---|
Healthy controls, n = 14 | 84.7 (72.4–87.2) | 15.3 (12.8–27.6) | 3.63 (2.34–7.54) | 3.76 (2.11–9.80) |
DMARD-naive RA group, n = 13 | 78.3 (63.9–88.3) | 21.7 (11.7–36.1) | 3.12 (1.72–5.73) | 2.23** (0.57–5.18) |
Active RA group, n = 19 | 79.9 (63.9–87.2) | 20.1 (12.8–36.1) | 2.76* (1.25–5.31) | 1.35***# (0.41–2.21) |
Remission group, n = 16 | 80.6 (66.6–90.1) | 19.4 (9.9–33.4) | 3.35 (2.13–7.21) | 2.98$ (1.34–4.89) |